Drug profile · INN
lutetium (177lu) oxodotreotide
LUTATHERA
lutetium (177lu) oxodotreotide (LUTATHERA) is a somatostatin receptor binding agent.
EMA: approved Various (V10) V10XX04
Patents linked 0
Pipeline programs 7
News articles 0
Drug details — lutetium (177lu) oxodotreotide
- Class
- Various (V10)
- Route
- —
- Patents
- 0
- Programs
- 7
- Data quality
- 0.83
Quick answer
lutetium (177lu) oxodotreotide (LUTATHERA) is a somatostatin receptor binding agent.
Key facts
INN lutetium (177lu) oxodotreotide
Brand LUTATHERA
Mechanism Somatostatin receptor binding agent
Target Somatostatin receptor
Therapeutic class Various (V10)
ATC code V10XX04
Mechanism of action
Somatostatin receptor binding agent
Primary target: Somatostatin receptor
Approval history
| Authority | Status | Date |
|---|---|---|
| EMA | approved | — |
Pipeline programs
Related & competitor drugs
Frequently asked questions
What is lutetium (177lu) oxodotreotide?
lutetium (177lu) oxodotreotide (LUTATHERA) is a somatostatin receptor binding agent.
What is the brand name for lutetium (177lu) oxodotreotide?
LUTATHERA is a marketed brand name for lutetium (177lu) oxodotreotide. Check FDA Drugs@FDA for the current US label holder and prescribing information.